Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON32733Phase 3Not yet recruiting
Phase 3, randomised trial in schizophrenia, schizoaffective disorder, schizophreniform disorder and 1 more comparing Clozapine with Olanzapine (2 arms). Primary endpoints: Substance use disorder reduction and Cost-effectiveness. Planned start Oct 2008; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON32733.